These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 26727230)

  • 1. Sepsis-induced immune dysfunction: can immune therapies reduce mortality?
    Delano MJ; Ward PA
    J Clin Invest; 2016 Jan; 126(1):23-31. PubMed ID: 26727230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune system's role in sepsis progression, resolution, and long-term outcome.
    Delano MJ; Ward PA
    Immunol Rev; 2016 Nov; 274(1):330-353. PubMed ID: 27782333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the apoptotic death of immune cells in sepsis.
    Luan YY; Yao YM; Xiao XZ; Sheng ZY
    J Interferon Cytokine Res; 2015 Jan; 35(1):17-22. PubMed ID: 25007137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Host immunosuppression in pathogenesis of sepsis and its clinical implication].
    Yao YM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):138-41. PubMed ID: 17376264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis.
    Ayala A; Chaudry IH
    Shock; 1996; 6 Suppl 1():S27-38. PubMed ID: 8828095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance and regulatory mechanisms of innate immune cells in the development of sepsis.
    Luan YY; Dong N; Xie M; Xiao XZ; Yao YM
    J Interferon Cytokine Res; 2014 Jan; 34(1):2-15. PubMed ID: 24006870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the understanding and treatment of sepsis-induced immunosuppression.
    Venet F; Monneret G
    Nat Rev Nephrol; 2018 Feb; 14(2):121-137. PubMed ID: 29225343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between Dendritic Cells and Immune Modulatory Agents against Sepsis.
    Wang G; Li X; Zhang L; Elgaili Abdalla A; Teng T; Li Y
    Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32197507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of monocytes/macrophages and their cytokines in the development of immunosuppression after severe injury].
    Jedynak M; Siemiatkowski A
    Pol Merkur Lekarski; 2002 Sep; 13(75):238-41. PubMed ID: 12474579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Precision evaluation of immune status and its significance in sepsis after burns or trauma].
    Yao YM; Luan Y
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):786-789. PubMed ID: 30481919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfer of naïve dendritic cells in resolving post-sepsis long-term immunosuppression.
    Laudanski K
    Med Hypotheses; 2012 Oct; 79(4):478-80. PubMed ID: 22840328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reversing ICU-acquired immunosuppression: an innovative biomarker-guided therapeutic strategy for decreasing sepsis mortality and nosocomial infection rate].
    Monneret G; Lepape A; Venet F
    Pathol Biol (Paris); 2011 Dec; 59(6):329-33. PubMed ID: 21981928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells.
    Mao Y; Poschke I; Kiessling R
    J Intern Med; 2014 Aug; 276(2):154-70. PubMed ID: 24597954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoregulatory Role of Myeloid-derived Cells in Inflammatory Bowel Disease.
    Leal MC; Däbritz J
    Inflamm Bowel Dis; 2015 Dec; 21(12):2936-47. PubMed ID: 26244650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-derived suppressor cells in sepsis.
    Lai D; Qin C; Shu Q
    Biomed Res Int; 2014; 2014():598654. PubMed ID: 24995313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Immunotherapeutics for Immunosuppression in Sepsis.
    Shin J; Jin M
    Biomol Ther (Seoul); 2017 Nov; 25(6):569-577. PubMed ID: 29081088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of immune dysfunction in determining outcome in acute liver failure.
    Antoniades CG; Berry PA; Wendon JA; Vergani D
    J Hepatol; 2008 Nov; 49(5):845-61. PubMed ID: 18801592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adjuvant PCEP induces recruitment of myeloid and lymphoid cells at the injection site and draining lymph node.
    Awate S; Wilson HL; Singh B; Babiuk LA; Mutwiri G
    Vaccine; 2014 May; 32(21):2420-7. PubMed ID: 24662707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting neutrophils in sepsis.
    Sônego F; Alves-Filho JC; Cunha FQ
    Expert Rev Clin Immunol; 2014 Aug; 10(8):1019-28. PubMed ID: 24867165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally occurring antimicrobial peptide OH-CATH30 selectively regulates the innate immune response to protect against sepsis.
    Li SA; Xiang Y; Wang YJ; Liu J; Lee WH; Zhang Y
    J Med Chem; 2013 Nov; 56(22):9136-45. PubMed ID: 24151910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.